These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37636902)

  • 1. Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization.
    Puebla Neira D; Zaidan M; Nishi S; Duarte A; Lau C; Parthasarathy S; Wang J; Kuo YF; Sharma G
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1827-1835. PubMed ID: 37636902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare utilization 9 months pre- and post- COVID-19 hospitalization among patients discharged alive.
    Zaidan M; Puebla Neira D; Polychronopoulou E; Yong-Fang K; Sharma G
    PLoS One; 2024; 19(6):e0303509. PubMed ID: 38900737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19.
    Figueira-Gonçalves JM; García-Bello MÁ; Ramallo-Fariña Y; Méndez R; Latorre Campos A; González-Jiménez P; Peces-Barba G; Molina-Molina M; España PP; García E; Domínguez-Pazos SJ; García Clemente M; Panadero C; de la Rosa-Carrillo D; Sibila O; Martínez-Pitarch MD; Toledo-Pons N; López-Ramirez C; Almonte-Batista W; Macías-Paredes A; Badenes-Bonet D; Pérez-Rodas EN; Lázaro J; Quirós Fernández S; Cordovilla R; Cano-Pumarega I; Torres A; Menendez R;
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2473-2481. PubMed ID: 37955022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 Pandemic on Chronic Obstructive Pulmonary Disease Healthcare Use, Exacerbations, and Mortality: A Population Study.
    Lam GY; Wen C; Ronksley PE; Bakal JA; Bhutani M; Soril LJJ; Stickland MK; Gross DP; Weatherald J
    Ann Am Thorac Soc; 2024 Sep; 21(9):1281-1288. PubMed ID: 38820253
    [No Abstract]   [Full Text] [Related]  

  • 5. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).
    Singh JA; Yu S
    Respir Res; 2016 Jan; 17():1. PubMed ID: 26739476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study.
    Clark B; Wells BJ; Saha AK; Franchino-Elder J; Shaikh A; Donato BMK; Ohar JA
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1483-1494. PubMed ID: 35791340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prediction strategy and care coordination for COPD readmissions.
    Bashir B; Schneider D; Naglak MC; Churilla TM; Adelsberger M
    Hosp Pract (1995); 2016 Aug; 44(3):123-8. PubMed ID: 27391991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission.
    Tran M; Xiang P; Rascati KL; Stock EM; Godley PJ; Coleman A; Bogart MR; Stanford RH
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1186-93. PubMed ID: 27668567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of readmissions following an initial COPD-related hospitalization.
    Baker CL; Zou KH; Su J
    Int J Chron Obstruct Pulmon Dis; 2013; 8():551-9. PubMed ID: 24348031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining 30-day COPD readmissions through the emergency department.
    Rezaee ME; Ward CE; Nuanez B; Rezaee DA; Ditkoff J; Halalau A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():109-120. PubMed ID: 29343950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.
    Simoni-Wastila L; Yang HW; Blanchette CM; Zhao L; Qian J; Dalal AA
    Curr Med Res Opin; 2009 Nov; 25(11):2729-35. PubMed ID: 19778165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What happened to the patients? Care trajectories for persons with a delayed hospital discharge during wave 1 of COVID-19 in Ontario, Canada; a population-based retrospective cohort study.
    Guilcher SJT; Bai YQ; Wodchis WP; Bronskill SE; Rashidian L; Kuluski K
    PLoS One; 2024; 19(9):e0309155. PubMed ID: 39331610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada.
    Dang-Tan T; Zhang S; Tavares RV; Stutz M; Ismaila AS; Vaillancourt J; Corriveau D; Stanford RH; Lin X; Nadeau GA; Simidchiev A; Parsons D; Sampalis JS
    Can Respir J; 2017; 2017():8184915. PubMed ID: 28713217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics Associated with Return Visits to the Emergency Department after COVID-19 Diagnosis.
    Husain I; O'Neill J; Mudge R; Bishop A; Soltany KA; Heinen J; Countryman C; Casey D; Cline D
    West J Emerg Med; 2021 Nov; 22(6):1257-1261. PubMed ID: 34787548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between asthma/chronic obstructive pulmonary disease overlap syndrome and healthcare utilization among the US adult population.
    Kim M; Tillis W; Patel P; Davis RM; Asche CV
    Curr Med Res Opin; 2019 Jul; 35(7):1191-1196. PubMed ID: 30612470
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Chronic Disease Home Telehealth Monitoring in the Veterans Health Administration on Healthcare Utilization and Mortality.
    Mohr NM; Vakkalanka JP; Holcombe A; Carter KD; McCoy KD; Clark HM; Gutierrez J; Merchant KAS; Bailey GJ; Ward MM
    J Gen Intern Med; 2023 Nov; 38(15):3313-3320. PubMed ID: 37157039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency Department Visits after Diagnosed Chronic Obstructive Pulmonary Disease in Aboriginal People in Alberta, Canada.
    Ospina MB; Rowe BH; Voaklander D; Senthilselvan A; Stickland MK; King M
    CJEM; 2016 Nov; 18(6):420-428. PubMed ID: 27180821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease.
    Sharma G; Kuo YF; Freeman JL; Zhang DD; Goodwin JS
    Arch Intern Med; 2010 Oct; 170(18):1664-70. PubMed ID: 20937926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.